Clone MPC11 is a mouse IgG2b isotype control antibody widely utilized in mouse research as a negative control to distinguish nonspecific background effects from those caused by test antibodies of the same isotype. This antibody, derived from the MPC11 cell line (a B lymphocyte from a mouse with plasmacytoma), has unknown specificity and is specifically chosen for its minimal crossreactivity after screening on various resting, activated, live, and fixed cells and tissues.

Primary In Vivo Applications

The main function of clone MPC11 in in vivo mouse studies is to serve as an isotypematched control for experiments using mouse IgG2b κ antibodies. When conducting in vivo research, investigators administer MPC11 at the same concentration as their test antibody to account for nonspecific effects that may arise from antibody administration itself, rather than from specific target binding.

Additional Research Applications

Beyond its primary role as an in vivo control, clone MPC11 is also employed in various laboratory techniques including flow cytometry, where it helps assess nonspecific binding to cells. The antibody is suitable for functional assays, immunohistochemistry (both frozen and paraffin sections), Western blotting, immunofluorescence, and immunoprecipitation.

Quality Standards for In Vivo Use

For in vivo applications, clone MPC11 is manufactured with stringent quality controls, typically achieving endotoxin levels of ≤12 EU/mg (with some preparations reaching <0.5 EU/mg) and purity levels of ≥9598%. These specifications are critical for in vivo studies to minimize confounding effects from contaminants that could trigger immune responses independent of the antibody's intended function.

Commonly used antibodies or proteins in the literature alongside MPC11 (a mouse IgG2b isotype control antibody) include those that serve as test or experimental antibodies in immunological studies, particularly:

• AntiPD1, AntiPDL1, and AntiCTLA4: These are immune checkpoint inhibitors used in mouse models to study immune modulation. MPC11 is specifically used as a negative control to match these functionally active IgG2b antibodies, ensuring any observed biological effects are due to the specificity of the test antibody and not the isotype itself.
• Depleting/functional antibodies: When studying immune cell depletion, other mouse IgG2b monoclonals targeting proteins such as CD4, CD8, or specific immune markers are used, with MPC11 serving as an isotype control for these depletion studies.
• Detection reagents in vitro: In ELISA or Western Blot, common pairs include:
  • Goat antirabbit secondary antibodies for detection in assays involving MPC11 or related cell lines, particularly those antibodies conjugated to alkaline phosphatase or HRP.
  • Caspase3, Caspase8, and Caspase9 antibodies: Used in studies on apoptosis pathways, often with MPC11 as a control for IgG2bspecific background in Western blotting.
• Fluorescent conjugates for flow cytometry: MPC11 as an IgG2b control is matched to test antibodies labeled with various fluorochromes, ensuring controls for nonspecific binding when using fluorochromeconjugated experimental antibodies in multicolor flow cytometry panels.

Summary of commonly used antibodies/proteins with MPC11:

MPC11 is not used to detect any particular protein; instead, its main function is as a negative control for mouse IgG2b to ensure background staining or nonspecific effects can be reliably distinguished from true positive signals produced by the test or experimental IgG2b antibody.

If you are working within a specific experimental context (e.g., immunooncology, neuroimmunology, flow cytometry), the commonly paired antibodies will align with the major targets of that research field, but the principles above remain the same.

Clone MPC11 is a mouse myeloma cell line that has been extensively used in scientific research, particularly in immunology and cancer studies. Here are some key findings from the scientific literature:

1. Immunoglobulin Class Switching: MPC11 is known for its role in studying immunoglobulin heavy chain class switching. It naturally produces IgG2b but can switch to produce IgG2a, allowing researchers to study class switching mechanisms in vitro.

2. Nonexpression of Heat Shock Genes: The MPC11 cell line has been found to have a silent major heat shock gene, which does not express even under stress conditions. This is attributed to transcriptional blockage rather than gene deletion or rearrangement.

3. Isotype Control in Research: MPC11 is widely used as an isotype control for mouse IgG2b antibodies in both in vivo and in vitro applications. It serves as a nonreactive comparator to ensure that any observed effects are due to the specificity of the experimental antibody rather than the IgG2b isotype itself.

4. Genetic Control of Hybrid Resistance: Studies involving MPC11 have shown that hybrid resistance to this plasmacytoma is controlled by a single gene, contrasting with other tumors that may involve multiple genes.

5. Cancer and Immunology Research: MPC11 has been instrumental in advancing our understanding of cancer biology and immunology. It is used to model various immunological processes and to study the dynamics of tumor growth and resistance.

Variation in Dosing Regimens of Clone MPC11 Across Mouse Models

Clone MPC11 refers to a mouse IgG2b isotype control antibody commonly used to assess nonspecific background binding in immunological assays, particularly as a negative control in preclinical mouse studies. Its dosing in vivo typically matches the dose and schedule of the primary, experimental IgG2b antibody being tested, rather than being adjusted for different mouse models.

General Dosing Principles

• Mirroring Test Antibody: Dosing regimens for MPC11 are usually selected to precisely mirror the experimental conditions of the primary antibody under investigation. For example, if a study administers a test IgG2b antibody at 200 µg every three days intraperitoneally, MPC11 would be given at the same dose and frequency.
• No ModelSpecific Adjustment: The available guidance and literature do not indicate that MPC11 dosing varies by mouse model (e.g., BALB/c, C57BL/6, NOD/SCID, etc.). Instead, the focus is on matching the experimental antibody, ensuring that any observed effects are due to the specific activity of the test antibody, not the isotype control.
• Flexibility in Application: While the main principle is to match the experimental antibody, the actual dose and schedule can vary widely depending on the research context—ranging from single highdose injections to repeated lower doses, depending on the protocol for the primary antibody.

Literature and Technical Guidance

• Product Documentation: Both Leinco and Bio X Cell state that MPC11 should be used at the same concentration as the primary antibody. This is a standard practice to ensure that any nonspecific effects (e.g., Fc receptor binding, complement activation) are accounted for in the control group.
• No Published ModelSpecific Protocols: A review of available product datasheets and published studies did not reveal modelspecific dosing recommendations; dosing is protocoldriven, not modeldriven.
• Practical Considerations: For flow cytometry and in vitro applications, the concentration may be titrated based on the assay, but for in vivo studies, the dose is protocolmatched to the experimental antibody.

Summary Table: MPC11 Dosing in Mouse Models

Conclusion

Dosing regimens for clone MPC11 in mouse models do not generally vary across different strains or tumor models. Instead, MPC11 is dosed identically to the experimental IgG2b antibody in each study, ensuring that any observed differences are attributable to the specific activity of the test antibody, not the isotype control. Researchers should consult their specific experimental protocol and primary antibody dosing to determine the appropriate MPC11 regimen.